Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 243.50 | N/A |
| PEG Ratio (TTM) | 9.01 | N/A |
| P/S Ratio (TTM) | 14.35 | N/A |
| P/B Ratio (TTM) | 21.23 | N/A |
| P/FCF Ratio (TTM) | 300.87 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.98% | N/A |
| ROE (TTM) | 9.10% | N/A |
| Net Profit Margin (TTM) | 5.88% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 133.09% | N/A | N/A |
| Revenue | 10.42% | N/A | N/A |
| Net Income | 136.25% | N/A | N/A |
| Cash Flow | 17.36% | N/A | N/A |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.93 | N/A |
| Quick Ratio (TTM) | 2.87 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 17.77 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |